For example, KAT6A showed a relatively higher mutation frequency in pancreatic and gastric cancers, and the majority of the mutations were missense mutations (Supplementary Figure 1), whereas CREBBP showed the highest mutation frequency than other genes in gastric and colorectal cancers. This evidence concerns the gene CREBBP and colorectal cancer.